The expression frequency of common fragile sites and genetic predisposition to colon cancer

Cancer Genetics and Cytogenetics

Volumn 119, Issue 2, 2000, Pages 139-145

  Tunca, Berrin ^a   Egeli, Ünal ^a   Zorluoglu, Abdullah ^a   Yllmazlar, Tuncay ^a   Yerci, Ömer ^a   Kizil, Ayhan ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER STAGING; CARCINOGENESIS; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CHROMOSOME FRAGILE SITE; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; GENETIC PREDISPOSITION; HUMAN; PEDIGREE ANALYSIS; PRIORITY JOURNAL;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ALU ELEMENTS; APHIDICOLIN; BROMODEOXYURIDINE; CAFFEINE; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME FRAGILE SITES; CHROMOSOME FRAGILITY; CHROMOSOMES, HUMAN; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; PEDIGREE;

EID: 0034043323     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(99)00228-9     Document Type: Article

References (33)

1. Pazy-Mino C., Penaherra S., Sanches E., Cordova A., Gutierrez S., Ocampo L., Leone P.E. Comparative study of chromosome aberrations induced with aphidicolin in women affected by breast cancer and cervix uterine cancer. Cancer Genet Cytogenet. 94:1997;120-124.
2. Sutherland G.R., Ledbetter D.H. Report of the committee on cytogenetic markers. Cytogenet Cell Genet. 51:1989;452-458.
3. Hecht F. Fragile sites, cancer chromosome breakpoints, and oncogenes all cluster in light G bands. Cancer Genet Cytogenet. 31:1988;17-24.
4. Manuelidis L. A view of interphase chromosomes. Science. 250:1990;1533-1540.
5. Zimonjic D.B., Druck T., Ohta M., Kastury K., Croce C.M., Popescu N.C., Huebner K. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene. Cancer Res. 57:1997;166-1170.
6. Vernole P., Tedeschi B., Caporossi D., Nicoletti B. A study on lymphocytes of neuroblastoma patients. Cancer Genet Cytogenet. 36:1988;13-23.
7. Porfirio B., Paladini P., Maccherini M., Gotti G., Cintorino M., De Marchi M. Patients with different lung cancer show expression of fra(3)(p14) in aphidicolin treated lymphocytes cultures. Cancer Genet Cytogenet. 43:1989;95-101.
8. Ardisia C., Venti G., Colozza M.V., Breschi C., Porfirio B., Davis S., Tanoto M., Donti E. Expression of aphidicolin-induced fragile sites in lymphocytes of patients with breast cancer. Cancer Genet Cytogenet. 67:1993;113-116.
9. Liu C., Wang G., Li P. The expression frequency of common fragile sites and genetic susceptibility to lung cancer. Cancer Genet Cytogenet. 42:1989;107-117.
10. Vernole P., Tedeschi B., Nicoletti B. Fragile sites induction by aphidicolin may be increased in parents of neuroblastoma patients. Cancer Genet Cytogenet. 50:1994;35-44.
11. Egeli Ü, Karadag M., Tunca B., Özyardimci N. The expression of common fragile sites and genetic predisposition to squamous cell lung cancers. Cancer Genet Cytogenet. 95:1997;153-158.
12. Simmers R.N., Sutherland G.R., West A., Richards R.I. Fragile sites at 16q22 are not at the breakpoint of the chromosomal rearrangements in acute myelomonocytic leukaemia. Science. 236:1987;92-94.
13. Sutherland G.R., Simmers R.N. No statistical association between common fragile sites and nonrandom chromosome breakpoints in cancer cells. Cancer Genet Cytogenet. 31:1988;9-15.
14. Zarr J.R. Biostatistical Analysis. 2nd Ed:1984;Prentice-Hall Inc, Englewood Cliffs.
15. Dave B.J., Hsu T.C., Hong W.K., Pathak S. Nonrandom distribution of mutagen-induced chromosome breaks in lymphocytes of patients with different malignancies. Int J Oncol. 5:1994;733-740.
16. Lea Beau M.M. Chromosomal fragile sites and cancer specific breakpoints. Cancer Genet Cytogenet. 31:1988;55-61.
17. Çeçener G., Egeli Ü, Tas,delen I., Tunca B., Duman H., Kizil A. Common fragile site expression and genetic predisposition to breast cancer. Teratogenesis Carcinog Mutagen. 18:1998;279-291.
18. Sutherland G.R. Fragile sites and cancer breakpoints. Cancer Genet Cytogenet. 31:1988;5-7.
19. Naylor S.L., Johnson B., Minna J.D., Sakaguchi A.Y. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Nature. 329:1987;451-454.
20. Brauch H., Johnson B., Hovis J., Yano T., Gazdar A., Pettengill O.S., Graziano S., Sorenson G.D., Poieesz B.J., Minna J., Linehan M., Zbar B. Molecular analysis of the short arm of chromosome 3 in small-cell and non-small-cell carcinoma of the lung. N Engl J Med. 317:1987;1109-1113.
21. Zbar B., Brauch H., Talmadge C., Linehan M. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature. 327:1987;721-724.
22. Zeiger M.A., Gnarra J.R., Zbar B., Linehan W.M., Pass H.I. Loss of heterozygosity on the short arm of chromosome 3 in mesothelioma cell lines and solid tumors. Genes Chromosom Cancer. 11:1994;15-20.
23. Zeiger M.A., Zbar B., Keiser H., Linehan W.M., Gnarra J.R. Loss of heterozygosity on the short arm of chromosome 3 in sporadic, von Hippel-Lindau disease-associated, and familial pheochromocytoma. Genes Chromosom Cancer. 13:1995;151-156.
24. Mooibroek H., Osinga J., Postmus P.E., Carritt B., Buys C.H. Loss of heterozygosity for a chromosome 3 sequence presumably at 3p21 in small cell lung cancer. Cancer Genet Cytogenet. 27:1987;361-365.
25. Kastury K., Baffa R., Duck T., Ohta M., Cotticelli M.G., Inoue H., Negrini M., Rugge M., Huang D., Croce C.M., Palazzo J., Huebner K. Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines. Cancer Res. 56:1996;978-983.
26. Sozzi G., Veronese M., Begrini M., Baffa R., Cotticelli M., Inoue H., Tornielli S., Pilotti S., De Gregori L., Pastorino U., Pierotti M., Ohta M., Huebner K., Croce C. The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell. 85:1996;17-26.
27. Thiagalingam S., Lisitsyn N.A., Hamaguchi M., Wigler M.H., Willson J.K.V., Markowitz S.D., Leach F.S., Kinzler K.W., Vogelstein B. Evaluation of the FHIT gene in colorectal cancers. Cancer Res. 56:1996;2936-2939.
28. Kok K., Osinga J., Davis B.M., van der Hout A.H., van der Veen A.Y., Landsvater R.M., de Leij L.F., Berendsen H.H., Postmus P.E.et al. Deletion of DNA sequence at the chromosomal region 3p21 in all major types of lung cancer. Nature. 330:1987;578-581.
29. Baba S. Recent advances in molecular genetics of colorectal cancer. World J Surg. 21:1997;678-687.
30. Rubinfeld B., Souzo B., Albert I., Muller O., Chamberlain S.H., Masiarz F.R., Munemitsu S., Polakis P. Association of the APC gene product with β-catenin. Science. 262:1993;1731-1734.
31. Su L.K., Vogelstein B., Kinzler K.W. Association of the APC tumor suppressor protein with catenins. Science. 262:1993;1734-1737.
32. Marra G., Boland C.R. Hereditary non-polyposis colorectal cancer. the syndrome, the genes, and historical perspectives J Natl Cancer Inst. 87:1995;1114-1125.
33. Schantz S.P., Hsu T.C. Mutagen-induced chromosome fragility within peripheral blood lymphocytes of head and neck cancer patients. Head Neck. 11:1989;337-342.